Agenda

All times displayed for Asia/Seoul timezone.

China Skinny

Nutrition and Health Food Claim Regulations in China & What They Mean to Consumers
10:15 - 10:55
Conference
Marketing Manager
China Skinny

Sponsored by:

China's health food market is a frantic space - on one hand businesses need to keep track of regulatory changes for the claims they make and on the other, do they make a difference with consumers? This session introduces some of the most relevant regulatory factors for making health food claims and some much needed context to understand what resonates and market perception.

Trends Impacting the Health Food Market in China
11:10 - 11:50
Conference
Marketing Manager
China Skinny

Sponsored by:

An engaging look at market trends and developments any business hoping to tackle China's health food market should be aware of. Whether it is newly-emerging channels or burgeoning industry opportunities, China offers a diligent brand many avenues to gain a foothold in an increasingly competitive market.

IQVIA

Molecule-to-Market: Three ways IQVIA uses machine learning to drive performance
10:15 - 11:00
Exhibitor Showcase
Director, Analytics Center of Excellence
IQVIA

Sponsored by:

YL Instruments

UHPLC for Your Innovative Lab
11:15 - 12:00
Exhibitor Showcase

Sponsored by:

1. Advantages of UHPLC for Quality Control and R&D in Pharmaceutical Field
2. UHPLC Features Comparing to HPLC
3. Naproxen (Nonsteroidal Antiinflammatory Drugs) Data Comparison by HPLC and UHPLC

OKAYA SEIRITSU ENGINEERING

Introduction of PCD PECX-1 for cGMP
11:15 - 12:00
Exhibitor Showcase

Sponsored by:

Introduction of OKAYA SEIRITSU Company PCD, which is the optimal solution of pressure relief management, energy saving, and TAB validation of GMP factory, hospital, and research institute, which is more demanded through WHO's Guide Line along with BIO industry growth.

MEDI-INSIGHT Corp.

Changes in ICH E6 GCP(R2) and Issues Concerning Safety Evaluation and Reporting of Clinical Trials
13:00 - 13:40
Conference
CEO
MEDI-INSIGHT Corp.

Please note: this session is provided in Korean language only, simultaneous translation is not provided for this session.

As Korean pharmaceutical companies are actively developing new drugs, clinical trials market size rapidly grows and environment to conduct clinical trials also significantly improves. In particular, Korea has fully implemented ICH E6 GCP since early 2000, promoting international harmonization of clinical trials standards.

The ICH E6 GCP was revised in 20 years in November, 2016 and there has been E6 addendum provided. In this seminar, we are going to talk about major changes following the revision of ICH E6, and the guidelines issued by MFDS last year focusing on safety evaluation and reporting of clinical trials, which has attracted keen attention.

MFDS

Current Trend in Pharmaceutical GMP Policy
13:55 - 14:35
Conference
Assistant Deputy Director
Minister of Food and Drug Safety

Sponsored by:

MORINAGA MILK INDUSTRY CO., LTD.

HRB (Human Residence Bifidobacteria) of Morinaga
14:00 - 14:45
Exhibitor Showcase

Sponsored by:

Speaker: tbd